2018 Access Epilepsy 
Veriheal
SEPTEMBER 16, 2020
It was approved in 2018 as a Schedule V substance, which is to say, a substance with a low potential for abuse considered not to be dangerous. But we know that cannabis is effective at helping to manage seizures caused by other forms of epilepsy— as well as other medical conditions —also. Epidiolex has a complex history.
Cannabis Law Report
JUNE 5, 2021
After leaving their home in Northern Ireland, Charlotte Caldwell and 15-year-old Billy, who suffers from refractory epilepsy and autism, have crossed by ferry to Great Britain on an expedition scheduled to end at the Houses of Parliament at Westminster on June 14. The Caldwells have three primary goals in mind as they journey across the U.K.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NORML
AUGUST 26, 2019
Then, in 2017 and 2018, Virginia finally made some moves to establish its own medical marijuana industry. While patients won’t be rolling up joints full of pungent flower, they can still access oils, tinctures, lozenges, inhalers, topicals, and pills packed with non-intoxicating CBD or THC-A, the acidic precursor of THC.
Veriheal
MAY 15, 2023
Since 2018, voters have attempted to pass adult use but have failed. Most state caregivers assist those unable or unable to access medical marijuana themselves, including children and those receiving hospice care. Registered caregivers approved by the state’s medical marijuana program are allowed to access medical marijuana legally.
CannaTech
JANUARY 16, 2019
Medical cannabis continued to pop up across the region year after year: imports in Brazil began in 2014, trials started in Chile in 2014, regulations were implemented in Colombia and Jamaica in 2015, the same followed in the Cayman Islands and parts of Argentina in 2016, Paraguay in 2017, and the list carries on from 2018 to date.
WeedAdvisor
SEPTEMBER 24, 2019
On June 25, 2018, the U.S. GW Pharmaceuticals created the medication after studies showed surprising success treating severe childhood epilepsy, specifically Lennox-Gastaut Syndrome and Dravet Syndrome. Thanks to the centralized nature of the European Union, this single approval essentially gives all members access to Epidiolex.
Project CBD
FEBRUARY 28, 2023
5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Accessed July 25, 2021. Accessed October 17, 2022.
Expert insights. Personalized for you.
98 
Let's personalize your content